Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27649059 | 0.76 | TYMS (0.42) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL406848 | 0.74 | TYMS (0.50) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL5359243 | 0.72 | ODC1 (0.45) | LMNANFKB1BLMPMP22ALDH1A1 | |
| SCHEMBL14860368 | 0.72 | ODC1 (0.45) | LMNANFKB1BLMPMP22ALDH1A1 | |
| SCHEMBL16267868 | 0.72 | TYMS (0.48) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL5540735 | 0.72 | TYMS (0.48) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL29088269 | 0.72 | TYMS (0.48) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL4413277 | 0.72 | TYMS (0.52) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL1285912 | 0.68 | TYMS (0.48) | TYMSGRM4LMNACYP3A4NFKB1 | |
| SCHEMBL3023034 | 0.67 | TYMS (0.46) | TYMSGRM4LMNACYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102176818-A | Antimicrobial gel formulations | NOVABAY PHARMACEUTICALS INC | 2011-09-07 | — | — | CN | claimed |
| EP-1896001-A1 | N-HALOGENATED AMINO ACIDS AND N, N-DIHALOGENATED AMINO ACIDS IN COMBINATION WITH HYPOHALOUS ACIDS | Novabay Pharmaceuticals, Inc. (US) | 2008-03-12 | — | — | EP | claimed |
| CN-101132785-A | N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acids | NOVABAY PHARMACEUTICALS INC (US) | 2008-02-27 | — | — | CN | claimed |
| WO-2006081392-A1 | N-HALOGENATED AMINO ACIDS AND N, N-DIHALOGENATED AMINO ACIDS IN COMBINATION WITH HYPOHALOUS ACIDS | NOVABAY PHARMACEUTICALS, INC. (US) | 2006-08-03 | — | — | WO | claimed |
| CN-102176818-A | Antimicrobial gel formulations | NOVABAY PHARMACEUTICALS INC | 2011-09-07 | — | — | CN | disclosed |
| CN-1902158-B | N,N-dihalogenated amino acids and derivatives | NOVACAL PHARMACEUTICALS INC | 2011-04-06 | — | — | CN | disclosed |
| CN-101132785-A | N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acids | NOVABAY PHARMACEUTICALS INC (US) | 2008-02-27 | — | — | CN | disclosed |
| CN-1902158-A | N,N-dihalogenated amino acids and derivatives | NOVACAL PHARMACEUTICALS INC (US) | 2007-01-24 | — | — | CN | disclosed |